Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hermansky-Pudlak syndrome without pulmonary fibrosis as a complication includes three relatively mild types (HPS-3, HPS-5 and HPS-6) of Hermansky-Pudlak syndrome (HPS), a multi-system disorder characterized by ocular or oculocutaneous albinism, bleeding diathesis and, in some cases, granulomatous colitis.
Biomarker and diagnostic research for Hermansky-Pudlak syndrome without pulmonary fibrosis has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for Hermansky-Pudlak syndrome without pulmonary fibrosis.
40 publications have been identified in PubMed for Hermansky-Pudlak syndrome without pulmonary fibrosis. Research spans Case Report / Case Series (40%), Basic Science / Preclinical (30%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 | 40% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:31 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Hermansky-Pudlak syndrome without pulmonary fibrosis
Laboratory research |
12 |
30% |
Testing and diagnosis research | 4 | 10% |
Research summaries | 4 | 10% |
Clinical study results | 2 | 5% |
New treatment approaches | 2 | 5% |
Sabelhaus T (2026). [PMID: 41911684](https://pubmed.ncbi.nlm.nih.gov/41911684/). *Rofo*. [Case Report / Case Series]
Giulianelli G (2026). [PMID: 42125657](https://pubmed.ncbi.nlm.nih.gov/42125657/). *Front Immunol*. [Case Report / Case Series]
Ghincea A (2026). [PMID: 40737518](https://pubmed.ncbi.nlm.nih.gov/40737518/). *American journal of respiratory cell and molecular biology*. [Case Report / Case Series]
Li X (2026). [PMID: 41953037](https://pubmed.ncbi.nlm.nih.gov/41953037/). *Front Immunol*. [Case Report / Case Series]
Chen S (2026). [PMID: 41909159](https://pubmed.ncbi.nlm.nih.gov/41909159/). *JCEM Case Rep*. [Case Report / Case Series]
Arif M (2026). [PMID: 40720784](https://pubmed.ncbi.nlm.nih.gov/40720784/). *American journal of respiratory cell and molecular biology*. [Case Report / Case Series]
Alcidi R (2025). [PMID: 40308332](https://pubmed.ncbi.nlm.nih.gov/40308332/). *Case reports in medicine*. [Basic Science / Preclinical]
Beck EA (2025). [PMID: 41000881](https://pubmed.ncbi.nlm.nih.gov/41000881/). *bioRxiv : the preprint server for biology*. [Basic Science / Preclinical]
Li L (2025). [PMID: 41116051](https://pubmed.ncbi.nlm.nih.gov/41116051/). *Cell biology and toxicology*. [Basic Science / Preclinical]
Serpa-Irizarry M (2025). [PMID: 40698202](https://pubmed.ncbi.nlm.nih.gov/40698202/). *Cureus*. [Case Report / Case Series]